LBRX vs LRCX · $803.4M cap vs P/E 71, rev $23.23B
LB Pharmaceuticals Inc Common Stock (LBRX) versus Lam Research Corp (LRCX) — a side-by-side from cached financials, not a winner call.
LB Pharmaceuticals Inc Common Stock (LBRX) is a biotechnology company listed on NASDAQ.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Timothy M. Archer.
LBRX does not have a complete income-statement cache yet.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
LBRX currently screens at market cap $803.4M. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Not investment advice. Open the LBRX and LRCX stock pages for the full models.
Not investment advice.